Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A More COMPLETE Picture of Revascularization in STEMI.
Køber L, Engstrøm T. Køber L, et al. Among authors: engstrom t. N Engl J Med. 2019 Oct 10;381(15):1472-1474. doi: 10.1056/NEJMe1910898. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475796 No abstract available.
Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.
Kelbaek H, Terkelsen CJ, Helqvist S, Lassen JF, Clemmensen P, Kløvgaard L, Kaltoft A, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Hansen HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Thuesen L. Kelbaek H, et al. Among authors: engstrom t. J Am Coll Cardiol. 2008 Mar 4;51(9):899-905. doi: 10.1016/j.jacc.2007.10.047. J Am Coll Cardiol. 2008. PMID: 18308157 Free article. Clinical Trial.
Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial.
Kelbaek H, Thuesen L, Helqvist S, Clemmensen P, Kløvgaard L, Kaltoft A, Andersen B, Thuesen H, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Hansen HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Lassen JF; DEDICATION Investigators. Kelbaek H, et al. Among authors: engstrom t. Circulation. 2008 Sep 9;118(11):1155-62. doi: 10.1161/CIRCULATIONAHA.107.758698. Epub 2008 Aug 25. Circulation. 2008. PMID: 18725489 Clinical Trial.
Left ventricular contractile function after distal protection in primary percutaneous coronary intervention: results from the Drug Elution and Distal Protection in ST-Elevation Myocardial Infarction trial.
Kofoed KF, Kelbæk H, Thuesen L, Poulsen SH, Hassager C, Andersen NH, Helqvist S, Lassen JF, Clemmensen P, Kløvgaard L, Kaltoft A, Engstrøm T, Krusell LR, Terkelsen CJ, Køber L. Kofoed KF, et al. Among authors: engstrom t. Int J Cardiol. 2011 Feb 3;146(3):395-8. doi: 10.1016/j.ijcard.2009.07.020. Epub 2009 Aug 22. Int J Cardiol. 2011. PMID: 19700209 Clinical Trial.
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.
Kaltoft A, Kelbaek H, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S. Kaltoft A, et al. Among authors: engstrom t. J Am Coll Cardiol. 2010 Aug 17;56(8):641-5. doi: 10.1016/j.jacc.2010.05.009. J Am Coll Cardiol. 2010. PMID: 20688033 Free article. Clinical Trial.
Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention.
Schoos MM, Kelbæk H, Kofoed KF, Køber L, Kløvgaard L, Helqvist S, Engstrøm T, Saunamäki K, Jørgensen E, Holmvang L, Clemmensen P. Schoos MM, et al. Among authors: engstrom t. Am J Cardiol. 2011 Jun 1;107(11):1597-603. doi: 10.1016/j.amjcard.2011.01.042. Epub 2011 Mar 23. Am J Cardiol. 2011. PMID: 21439539
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Lønborg J, Vejlstrup N, Kelbæk H, Bøtker HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Køber L, Treiman M, Holst JJ, Engstrøm T. Lønborg J, et al. Among authors: engstrom t. Eur Heart J. 2012 Jun;33(12):1491-9. doi: 10.1093/eurheartj/ehr309. Epub 2011 Sep 14. Eur Heart J. 2012. PMID: 21920963 Clinical Trial.
Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.
Lønborg J, Kelbæk H, Vejlstrup N, Bøtker HE, Kim WY, Holmvang L, Jørgensen E, Helqvist S, Saunamäki K, Terkelsen CJ, Schoos MM, Køber L, Clemmensen P, Treiman M, Engstrøm T. Lønborg J, et al. Among authors: engstrom t. Circ Cardiovasc Interv. 2012 Apr;5(2):288-95. doi: 10.1161/CIRCINTERVENTIONS.112.968388. Epub 2012 Apr 10. Circ Cardiovasc Interv. 2012. PMID: 22496084 Clinical Trial.
Comparison of Selvester QRS score with magnetic resonance imaging measured infarct size in patients with ST elevation myocardial infarction.
Carlsen EA, Bang LE, Ahtarovski KA, Engstrøm T, Køber L, Kelbæk H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Wagner GS, Lønborg J. Carlsen EA, et al. Among authors: engstrom t. J Electrocardiol. 2012 Jul-Aug;45(4):414-419. doi: 10.1016/j.jelectrocard.2012.03.007. Epub 2012 May 1. J Electrocardiol. 2012. PMID: 22554459
373 results